• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴西圣埃斯皮里图州肝细胞癌和肝硬化 TP53 突变分析反映了中水平的黄曲霉毒素膳食暴露。

Hepatocellular carcinoma and liver cirrhosis TP53 mutation analysis reflects a moderate dietary exposure to aflatoxins in Espírito Santo State, Brazil.

机构信息

Núcleo de Genética Humana e Molecular, Departamento de Ciências Biológicas, Centro de Ciências Humanas e Naturais, Universidade Federal do Espírito Santo, Av. Marechal Campos 1468, Campus de Maruípe, Vitória, Espírito Santo, CEP 29040-090, Brazil.

出版信息

Mol Biol Rep. 2013 Aug;40(8):4883-7. doi: 10.1007/s11033-013-2587-2. Epub 2013 May 7.

DOI:10.1007/s11033-013-2587-2
PMID:23649769
Abstract

The close relationship between aflatoxins and 249ser TP53 gene mutation (AGG to AGT, Arg to Ser) in hepatocellular carcinoma (HCC) makes this mutation an indirect indicator of dietary contamination with this toxin. We have examined the prevalence of codon 249 TP53 mutation in 41 HCC and 74 liver cirrhosis (without HCC) cases diagnosed at the HUCAM University Hospital in Vitoria, Espírito Santo State, Brazil. DNA was extracted from paraffin sections and from plasma. The mutation was detected by DNA amplification, followed by restriction endonuclease digestion and confirmed by direct sequencing. DNA restriction showed 249ser mutation in 16 HCC and 13 liver cirrhosis, but sequencing confirmed mutations in only 6 HCC and 1 liver cirrhosis. In addition, sequencing revealed 4 patients with mutations at codon 250 (250ser and 250leu) in HCC cases. The prevalence of TP53 mutation was 10/41 (24.3%) in HCC and 1/74 (1.4%) in liver cirrhosis. No relationship between the presence of mutations and the etiology of HCC was observed. TP53 exon 7 mutations, which are related to aflatoxins exposure, were found at 14.6% (249ser), 7.3% (250leu) and 2.4% (250ser) in 41 cases of HCC and 1.4% in 74 liver cirrhosis (without HCC) cases, suggesting a moderate dietary exposure to aflatoxins in the Espírito Santo State, Brazil.

摘要

黄曲霉毒素与肝癌中 249 位丝氨酸 TP53 基因突变(AGG 突变为 AGT,精氨酸变为丝氨酸)密切相关,使该突变成为这种毒素饮食污染的间接指标。我们检查了巴西圣埃斯皮里图州维多利亚市 HUCAM 大学医院诊断的 41 例肝癌和 74 例肝硬化(无肝癌)病例中 249 位 TP53 密码子突变的流行情况。从石蜡切片和血浆中提取 DNA。通过 DNA 扩增检测突变,然后用限制性内切酶消化,并通过直接测序确认。DNA 限制显示 16 例 HCC 和 13 例肝硬化存在 249 位丝氨酸突变,但测序仅证实 6 例 HCC 和 1 例肝硬化存在突变。此外,测序还发现 4 例 HCC 病例在 250 位密码子发生突变(250 位丝氨酸和 250 位亮氨酸)。肝癌中 TP53 突变的患病率为 10/41(24.3%),肝硬化中为 1/74(1.4%)。未观察到突变的存在与 HCC 的病因之间存在关系。在 41 例 HCC 病例中,TP53 外显子 7 突变与黄曲霉毒素暴露有关,分别为 14.6%(249 位丝氨酸)、7.3%(250 位亮氨酸)和 2.4%(250 位丝氨酸),而在 74 例无 HCC 的肝硬化病例中,这一比例为 1.4%,表明巴西圣埃斯皮里图州的饮食中存在中等程度的黄曲霉毒素暴露。

相似文献

1
Hepatocellular carcinoma and liver cirrhosis TP53 mutation analysis reflects a moderate dietary exposure to aflatoxins in Espírito Santo State, Brazil.巴西圣埃斯皮里图州肝细胞癌和肝硬化 TP53 突变分析反映了中水平的黄曲霉毒素膳食暴露。
Mol Biol Rep. 2013 Aug;40(8):4883-7. doi: 10.1007/s11033-013-2587-2. Epub 2013 May 7.
2
Ser-249 p53 mutations in plasma DNA of patients with hepatocellular carcinoma from The Gambia.来自冈比亚的肝细胞癌患者血浆DNA中的Ser-249 p53突变
J Natl Cancer Inst. 2000 Jan 19;92(2):148-53. doi: 10.1093/jnci/92.2.148.
3
Quantitative analysis of plasma TP53 249Ser-mutated DNA by electrospray ionization mass spectrometry.通过电喷雾电离质谱法对血浆中TP53 249Ser突变DNA进行定量分析。
Cancer Epidemiol Biomarkers Prev. 2005 Dec;14(12):2956-62. doi: 10.1158/1055-9965.EPI-05-0612.
4
TP53 R249S mutations, exposure to aflatoxin, and occurrence of hepatocellular carcinoma in a cohort of chronic hepatitis B virus carriers from Qidong, China.中国启东慢性乙型肝炎病毒携带者队列中TP53 R249S突变、黄曲霉毒素暴露与肝细胞癌发生情况
Cancer Epidemiol Biomarkers Prev. 2009 May;18(5):1638-43. doi: 10.1158/1055-9965.EPI-08-1102. Epub 2009 Apr 14.
5
249 TP53 mutation has high prevalence and is correlated with larger and poorly differentiated HCC in Brazilian patients.249例TP53突变在巴西患者中具有高发生率,且与更大且分化差的肝癌相关。
BMC Cancer. 2009 Jun 26;9:204. doi: 10.1186/1471-2407-9-204.
6
249(ser) TP53 mutation in plasma DNA, hepatitis B viral infection, and risk of hepatocellular carcinoma.血浆DNA中249(丝氨酸)TP53突变、乙型肝炎病毒感染与肝细胞癌风险
Oncogene. 2005 Sep 1;24(38):5858-67. doi: 10.1038/sj.onc.1208732.
7
Plasma 249Ser p53 mutation in patients with hepatocellular carcinoma residing in a high risk area.高风险地区肝细胞癌患者血浆中249Ser p53突变情况
J Cell Mol Med. 2003 Jan-Mar;7(1):89-92. doi: 10.1111/j.1582-4934.2003.tb00207.x.
8
Codon 249 mutation in exon 7 of p53 gene in plasma DNA: maybe a new early diagnostic marker of hepatocellular carcinoma in Qidong risk area, China.血浆DNA中p53基因第7外显子密码子249突变:可能是中国启东高危地区肝细胞癌新的早期诊断标志物。
World J Gastroenterol. 2003 Apr;9(4):692-5. doi: 10.3748/wjg.v9.i4.692.
9
The prevalence of the mutation in codon 249 of the P53 gene in patients with hepatocellular carcinoma (HCC) in Turkey.土耳其肝细胞癌(HCC)患者中P53基因第249位密码子突变的发生率。
J Gastrointest Cancer. 2010 Sep;41(3):185-9. doi: 10.1007/s12029-010-9140-5.
10
Ser-249 TP53 and CTNNB1 mutations in circulating free DNA of Egyptian patients with hepatocellular carcinoma versus chronic liver diseases.埃及肝细胞癌患者与慢性肝病患者循环游离DNA中Ser-249 TP53和CTNNB1突变情况
Cancer Lett. 2008 Jun 18;264(2):201-8. doi: 10.1016/j.canlet.2008.01.031. Epub 2008 Mar 3.

引用本文的文献

1
Integrated MicroRNA Expression Profile Reveals Dysregulated miR-20a-5p and miR-200a-3p in Liver Fibrosis.整合 microRNA 表达谱揭示肝纤维化中失调的 miR-20a-5p 和 miR-200a-3p。
Biomed Res Int. 2021 Jun 8;2021:9583932. doi: 10.1155/2021/9583932. eCollection 2021.
2
Aflatoxin and viral hepatitis exposures in Guatemala: Molecular biomarkers reveal a unique profile of risk factors in a region of high liver cancer incidence.危地马拉的黄曲霉毒素与病毒性肝炎暴露:分子生物标志物揭示了肝癌高发地区独特的风险因素概况。
PLoS One. 2017 Dec 13;12(12):e0189255. doi: 10.1371/journal.pone.0189255. eCollection 2017.
3

本文引用的文献

1
Hepatocellular carcinoma.肝细胞癌
N Engl J Med. 2011 Sep 22;365(12):1118-27. doi: 10.1056/NEJMra1001683.
2
Clinical and epidemiological aspects of hepatocellular carcinoma in Brazil.巴西肝细胞癌的临床和流行病学特征。
Clinics (Sao Paulo). 2010;65(12):1285-90. doi: 10.1590/s1807-59322010001200010.
3
The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective.肝细胞癌的发病率和流行病学:全球和区域视角。
DNA markers in molecular diagnostics for hepatocellular carcinoma.
用于肝细胞癌分子诊断的DNA标志物
Expert Rev Mol Diagn. 2014 Sep;14(7):803-17. doi: 10.1586/14737159.2014.946908. Epub 2014 Aug 7.
Oncologist. 2010;15 Suppl 4:5-13. doi: 10.1634/theoncologist.2010-S4-05.
4
Hepatocellular carcinoma: A global view.肝细胞癌:全球视角。
Nat Rev Gastroenterol Hepatol. 2010 Aug;7(8):448-58. doi: 10.1038/nrgastro.2010.100. Epub 2010 Jul 13.
5
249 TP53 mutation has high prevalence and is correlated with larger and poorly differentiated HCC in Brazilian patients.249例TP53突变在巴西患者中具有高发生率,且与更大且分化差的肝癌相关。
BMC Cancer. 2009 Jun 26;9:204. doi: 10.1186/1471-2407-9-204.
6
249ser p53 mutation in the serum of black southern African patients with hepatocellular carcinoma.南非南部黑人肝细胞癌患者血清中的249ser p53突变
J Gastroenterol Hepatol. 2005 Aug;20(8):1185-90. doi: 10.1111/j.1440-1746.2005.03951.x.
7
249(ser) TP53 mutation in plasma DNA, hepatitis B viral infection, and risk of hepatocellular carcinoma.血浆DNA中249(丝氨酸)TP53突变、乙型肝炎病毒感染与肝细胞癌风险
Oncogene. 2005 Sep 1;24(38):5858-67. doi: 10.1038/sj.onc.1208732.
8
Codon 249 mutation in exon 7 of p53 gene in plasma DNA: maybe a new early diagnostic marker of hepatocellular carcinoma in Qidong risk area, China.血浆DNA中p53基因第7外显子密码子249突变:可能是中国启东高危地区肝细胞癌新的早期诊断标志物。
World J Gastroenterol. 2003 Apr;9(4):692-5. doi: 10.3748/wjg.v9.i4.692.
9
Circulating nucleic acids in plasma and serum as a noninvasive investigation for cancer: time for large-scale clinical studies?血浆和血清中的循环核酸作为癌症的非侵入性检测手段:开展大规模临床研究的时候到了吗?
Int J Cancer. 2003 Jan 10;103(2):149-52. doi: 10.1002/ijc.10791.
10
Codon 249 mutations of p53 gene in non-neoplastic liver tissues.非肿瘤性肝组织中p53基因的249位密码子突变
World J Gastroenterol. 1999 Aug;5(4):324-326. doi: 10.3748/wjg.v5.i4.324.